Efficacy, Safety, and Adverse Effects of Finasteride and Dutasteride in Treating Benign Prostatic Hyperplasia: A Retrospective Cohort Study
December 2024
in “
Zanco Journal of Medical Sciences
”
Studysummary In this retrospective cohort study, researchers found no significant difference between finasteride and dutasteride in terms of reducing prostate volume or adverse effects among patients with benign prostatic hyperplasia, although both drugs improved lower urinary tract symptoms over one year by reducing prostate volume.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study evaluated 170 patients with benign prostatic hyperplasia, comparing finasteride (77 patients) and dutasteride (93 patients) over one year. Both drugs significantly reduced prostate volume and improved lower urinary tract symptoms, with no significant differences in efficacy or adverse effects between them. The study concluded that finasteride and dutasteride are equally effective and safe for treating BPH over a one-year period.
